Elicio Therapeutics, Inc. Gain (Loss) on Disposition of Assets
Elicio Therapeutics, Inc. (ELTX) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2022-03-30
- Elicio Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2021 was $0.00.
- Elicio Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2020 was -$58.00K.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2020-12-31 | -$58.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |